Last news
Tesco's Clubcard Challenges, Powered by Eagle Eye, Wins "Best Global Loyalty Launch or Initiative" at the 2025 International Loyalty Awards

Tesco's Clubcard Challenges, Powered by Eagle Eye, Wins "Best Global Loyalty Launch or Initiative" at the 2025 International Loyalty Awards

LONDON, May 28, 2025 /PRNewswire/ -- Tesco's Clubcard Challenges, powered by Eagle Eye's Personalised Challenges solution, has been named the Best Global Loyalty Launch or Initiative at the 2025 International Loyalty Awards. The award celebrates...

NX China Acquires GDP Certification for Shanghai and Lianyungang Facilities

NX China Acquires GDP Certification for Shanghai and Lianyungang Facilities

- Establishing High-quality Pharmaceutical Logistics Service Systems - TOKYO, May 28, 2025 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereafter "NX China"), a group company of NIPPON EXPRESS HOLDINGS, INC., has received Good Distribution...

Hollywood-Bound: Local Family-Owned Wellness Brand Takes Centre Stage in Hollywood's Coveted Mother's Day Gift Bag

Hollywood-Bound: Local Family-Owned Wellness Brand Takes Centre Stage in Hollywood's Coveted Mother's Day Gift Bag

GOLD COAST, Australia, May 28, 2025 /PRNewswire/ -- Australian family-owned and operated, Biosota Organics has officially gone Hollywood. The brand's award-winning high MGO-rated Manuka honey was featured in the highly anticipated 2025 Hollywood...

EpiVax Appoints Dr. Vibha Jawa to Lead Scientific Strategy as CSO

EpiVax Appoints Dr. Vibha Jawa to Lead Scientific Strategy as CSO

PROVIDENCE, R.I., May 28, 2025 /PRNewswire/ -- EpiVax, Inc., a leader in preclinical immunogenicity assessment for biologic therapeutics and vaccines, is pleased to announce the appointment of Vibha Jawa, PhD, FAAPS as Chief Scientific Officer. Dr....

Experimental Drug Development Centre Granted U.S. FDA Fast Track Designation for Antibody-Drug Conjugate EBC-129 to Treat Pancreatic Ductal Adenocarcinoma

Experimental Drug Development Centre Granted U.S. FDA Fast Track Designation for Antibody-Drug Conjugate EBC-129 to Treat Pancreatic Ductal Adenocarcinoma

EBC-129 is the first made-in-Singapore antibody-drug conjugate (ADC) to enter clinical development. It selectively targets a tumour-specific N-glycosylated epitope on both CEACAM5 and CEACAM6. The Fast Track Designation highlights the potential of...

D-Link Unveils the New DBR Router & Access Point

D-Link Unveils the New DBR Router & Access Point

Empowering Secure, Seamless Connectivity for Small Businesses TAIPEI, May 28, 2025 /PRNewswire/ -- D-Link Corporation (TWSE: 2332), a global leader in networking solutions, is pleased to announce the launch of its latest DBR Series, which includes...

Timekettle Unveils the NEW T1 AI Translator: The World's Fastest Offline Translation Device

Timekettle Unveils the NEW T1 AI Translator: The World's Fastest Offline Translation Device

Rapid Response Time and Increased Offline Translation Accuracy via Edge AI for Revolutionary Real-time Communication PLANO, Texas, May 28, 2025 /PRNewswire/ -- Timekettle, a global leader in AI-powered translation technology, announces the New T1 AI...

Four New Series Debut under TOMY's "T-SPARK" Hobby Label for High-end Customers: Q VILLAGE, COLLEKAZARO, SPARK Fig, LEGACYSOUL; Reservations to Start Sequentially from June

Four New Series Debut under TOMY's "T-SPARK" Hobby Label for High-end Customers: Q VILLAGE, COLLEKAZARO, SPARK Fig, LEGACYSOUL; Reservations to Start Sequentially from June

- In Collaboration with Popular Works Such as "Back to the Future," "The Fast & Furious," and "My Hero Academia" - TOKYO, May 28, 2025 /PRNewswire/ -- TOMY Company, Ltd., based in Katsushika Ward, Tokyo, has announced four new series from the...

menu
menu